James Dyett, OpenAI's Head of Sales who joined during the company's rapid growth phase in 2023, announced his departure to take a new role as Operator in Residence at venture capital firm Thrive Capital. Dyett led key sales efforts including enterprise and API sales at OpenAI, which is now valued at over $850 billion. His exit follows several recent leadership changes at OpenAI, including medical leaves and role transitions among top executives. Dyett expressed enthusiasm for supporting startups at Thrive, a long-term backer of OpenAI, signaling a shift back to early-stage company building for him.
The 2026 State of Sustainable Fleets Market Brief reveals that commercial fleets are adapting to a third year of freight recession and major federal policy changes by diversifying powertrain technologies and fuels. Despite federal funding cuts and ta...
Therini Bio has started dosing patients in a Phase 1b trial for THN391, a novel antibody targeting fibrin-driven inflammation in diabetic macular edema (DME). This therapy aims to reduce neuroinflammation and retinal degeneration without affecting bl...
ResVR has introduced an AI-powered assistant integrated into its 3D virtual homebuying platform, enabling buyers to navigate, customize, and make decisions with real-time voice interaction. This assistant offers 24/7 support, multi-language accessibi...
China's securities regulator fined online brokerages Futu and UP Fintech a combined $331 million for operating unlicensed cross-border stock trading services. While both companies must wind down their China operations, the penalties remove a long-sta...
Privia Health Group, a national physician enablement company, announced its expansion into New Jersey through a partnership with Neurology Group of Bergen County (NGBC), a large neurology practice with 25 clinicians. NGBC will anchor the new Privia M...
